Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13051
PUT
Gencor Industries
GENC
$268M
| $22.9K | ﹤0.01% |
1,300
+900
| +225% | +$18.6K |
2024 Q3
1 quarter
|
|
13052
PUT
Gain Therapeutics
GANX
$73.8M
| $22.9K | ﹤0.01% |
+10,600
| New | +$21.3K |
2024 Q4
0 quarters
|
|
13053
CALL
Presidio Property Trust
SQFT
$1.49M
| $22.9K | ﹤0.01% |
2,860
+1,010
| +55% | +$7.01K |
2024 Q1
3 quarters
|
|
13054
CALL
Backblaze
BLZE
$848M
| $22.9K | ﹤0.01% |
3,800
-11,200
| -75% | -$76.1K |
2021 Q4
12 quarters
|
|
|
MGIC
13055
PUT
DELISTED
Magic Software Enterprises
MGIC
| $22.9K | ﹤0.01% |
1,900
+900
| +90% | +$10.4K |
2022 Q1
11 quarters
|
|
13056
PUT
Gladstone Capital
GLAD
$429M
| $22.8K | ﹤0.01% |
800
-200
| -20% | -$5.18K |
2022 Q4
8 quarters
|
|
|
NFGC
13057
CALL
New Found Gold
NFGC
$611M
| $22.8K | ﹤0.01% |
12,500
+6,500
| +108% | +$13.3K |
2024 Q3
1 quarter
|
|
13058
CALL
OraSure Technologies
OSUR
$266M
| $22.7K | ﹤0.01% |
6,300
+4,100
| +186% | +$16.3K |
2020 Q1
19 quarters
|
|
13059
Mid-America Apartment Communities
MAA
$13.7B
| $22.7K | ﹤0.01% |
147
-20
| -12% | -$3.12K |
2024 Q3
1 quarter
|
|
13060
CALL
Blue Owl Capital
OBDC
$4.99B
| $22.7K | ﹤0.01% |
1,500
-2,100
| -58% | -$31.6K |
2021 Q4
12 quarters
|
|
13061
PUT
Invesco DB Base Metals Fund
DBB
$364M
| $22.6K | ﹤0.01% |
1,200
-3,300
| -73% | -$66.9K |
2023 Q4
4 quarters
|
|
13062
CALL
Amplify Seymour Cannabis ETF
CNBS
$70.5M
| $22.6K | ﹤0.01% |
917
+567
| +162% | +$24.7K |
2024 Q3
1 quarter
|
|
13063
Rockwell Medical
RMTI
$33M
| $22.5K | ﹤0.01% |
1,104
-1,238
| -53% | -$36.1K |
2023 Q4
4 quarters
|
|
13064
PUT
Select Water Solutions
WTTR
$2.55B
| $22.5K | ﹤0.01% |
1,700
-10,500
| -86% | -$133K |
2024 Q3
1 quarter
|
|
13065
CALL
UNIFI
UFI
$122M
| $22.5K | ﹤0.01% |
3,600
-8,300
| -70% | -$50.8K |
2022 Q3
9 quarters
|
|
13066
CALL
DocGo
DCGO
$35.9M
| $22.5K | ﹤0.01% |
5,300
-5,800
| -52% | -$22.3K |
2022 Q1
11 quarters
|
|
13067
CALL
Zentalis Pharmaceuticals
ZNTL
$255M
| $22.4K | ﹤0.01% |
7,400
-12,300
| -62% | -$40.3K |
2021 Q2
14 quarters
|
|
13068
LiqTech
LIQT
$15.5M
| $22.4K | ﹤0.01% |
+12,378
| New | +$24.2K |
2024 Q4
0 quarters
|
|
13069
CALL
iShares MSCI Sweden ETF
EWD
$956M
| $22.4K | ﹤0.01% |
600
| – | – |
2023 Q3
5 quarters
|
|
|
FIAT
13070
CALL
YieldMax Short COIN Option Income Strategy ETF
FIAT
$29.4M
| $22.4K | ﹤0.01% |
240
+220
| +1,100% | +$27.4K |
2024 Q3
1 quarter
|
|
13071
PUT
Amtech Systems
ASYS
$313M
| $22.3K | ﹤0.01% |
4,100
| – | – |
2022 Q4
8 quarters
|
|
|
MBAI
13072
MBody AI Ltd. Ordinary Share
MBAI
$48.9M
| $22.3K | ﹤0.01% |
+3,219
| New | +$23.9K |
2024 Q4
0 quarters
|
|
|
CCC
13073
PUT
CCC Intelligent Solutions
CCC
$3.88B
| $22.3K | ﹤0.01% |
1,900
+800
| +73% | +$9.27K |
2022 Q4
8 quarters
|
|
13074
PUT
Legacy Housing
LEGH
$695M
| $22.2K | ﹤0.01% |
900
-400
| -31% | -$10.3K |
2022 Q4
8 quarters
|
|
|
BTAI
13075
PUT
DELISTED
BioXcel Therapeutics
BTAI
| $22.2K | ﹤0.01% |
3,713
+1,982
| +115% | +$16.6K |
2020 Q1
19 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.